Type I interferon in chronic virus infection and cancer

LM Snell, TL McGaha, DG Brooks - Trends in immunology, 2017 - cell.com
Type I interferons (IFN-Is) are emerging as key drivers of inflammation and
immunosuppression in chronic infection. Control of these infections requires IFN-I signaling; …

CDK inhibitors: positive and negative regulators of G1-phase progression

CJ Sherr, JM Roberts - Genes & development, 1999 - genesdev.cshlp.org
Mitogen-dependent progression through the first gap phase (G1) and initiation of DNA
synthesis (S phase) during the mammalian cell division cycle are cooperatively regulated by …

The cell cycle: a review

KA Schafer - Veterinary pathology, 1998 - journals.sagepub.com
The cell cycle is a complex process that involves numerous regulatory proteins that direct
the cell through a specific sequence of events culminating in mitosis and the production of …

New functional activities for the p21 family of CDK inhibitors.

J LaBaer, MD Garrett, LF Stevenson… - Genes & …, 1997 - genesdev.cshlp.org
The association of cdk4 with D-type cyclins to form functional kinase complexes is
comparatively inefficient. This has led to the suggestion that assembly might be a regulated …

The p16INK4a/CDKN2A tumor suppressor and its relatives

M Ruas, G Peters - Biochimica et Biophysica Acta (BBA)-Reviews on …, 1998 - Elsevier
In late 1993 and early 1994, two distinct lines of research converged on a new tumor
suppressor gene located on human chromosome 9p21. The órst report was of the existence …

The intersection of COVID-19 and cancer: signaling pathways and treatment implications

Z Zong, Y Wei, J Ren, L Zhang, F Zhou - Molecular cancer, 2021 - Springer
The outbreak of the novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a serious public health …

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

MW Landis, BS Pawlyk, T Li, P Sicinski, PW Hinds - Cancer cell, 2006 - cell.com
Cyclin D1 is a multifunctional protein that activates CDK4 and CDK6, titrates Cip/Kip CDK
inhibitors to increase CDK2 activity, and modulates the function of certain transcription …

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

S Rao, DC Porter, X Chen, T Herliczek… - Proceedings of the …, 1999 - National Acad Sciences
In this paper we present the finding that lovastatin arrests cells by inhibiting the proteasome,
which results in the accumulation of p21 and p27, leading to G1 arrest. Lovastatin is an …

[HTML][HTML] Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases

M Grimmler, Y Wang, T Mund, Z Cilenšek, EM Keidel… - Cell, 2007 - cell.com
Summary p27 Kip1 controls cell proliferation by binding to and regulating the activity of
cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are …

Inhibitory Effects of 1α,25-Dihydroxyvitamin D3 on the G1–S Phase-Controlling Machinery

SS Jensen, MW Madsen, J Lukas… - Molecular …, 2001 - academic.oup.com
Abstract The nuclear hormone 1α, 25-dihydroxyvitamin D3 induces cell cycle arrest,
differentiation, or apoptosis depending on target cell type and state. Although the …